Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- GSK completes acquisition of TESARO, an oncology focused biopharmaceutical company
- GSK announces succession plan to appoint new Chairman
- Two positive phase III studies of tafenoquine for the radical cure of Plasmodium vivax malaria published in The New England Journal of Medicine
Tweets from GSK
-
GSK @GSK
Partnership is critical to addressing diseases impacting the world’s poorest. Thanks for having us at the #GFINDER report launch @PCuresResearch!
about 15 hours ago
-
GSK @GSK
The #GFINDER results show progress in investment in neglected disease R&D, but we need a broader funding base and risk-sharing in global health to ensure sustainability. @PCuresResearch
about 17 hours ago -
GSK @GSK
As one of the few companies committed to researching treatments and vaccines for #HIV, #TB and #malaria we’re proud to be talking with @PCuresResearch @DNDi @UNITAID @WHO and others today about investment in R&D for neglected diseases #GFINDER #globalhealth #GlobalGoals
about 21 hours ago
